S. Aaltomaa
Papers
1
Total Citations
23
H-Index
1
About
S. Aaltomaa is a leading clinical researcher in urologic oncology, with a primary focus on advancing stereotactic body radiotherapy (SBRT) for localized prostate cancer. Her most impactful work, the 2020 study "Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results" (23 citations), provides critical long-term evidence supporting SBRT as a primary treatment modality. This real-life, non-selected patient analysis demonstrates Aaltomaa's commitment to translating cutting-edge radiation techniques into practical, durable outcomes for men with clinically localized disease. By rigorously evaluating 5-year efficacy, her research helps solidify SBRT's role as an emerging standard of care, offering patients a shorter, more convenient treatment course without compromising oncologic control. Aaltomaa's contributions are particularly valuable for bridging the gap between clinical trials and everyday practice, ensuring that high-quality evidence guides treatment decisions. Her work continues to influence radiation oncology protocols and patient counseling, making her a respected voice in the evolving landscape of prostate cancer management.
Research Focus
Key Achievements
Top Papers
- 1